City Therapeutics

Drug DiscoveryWebsite
Current Valuation
$285.5M
As of October 8, 2024
Total Funding Raised
$139.5M
Across 1 round
Last Round
Early Stage VC

$135.0M

Last Funding
Oct 2024

Funding date

Capital Efficiency
2.05x

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
DateRoundAmountPost-ValuationGrowth
October 8, 2024Early Stage VC (Series A)$135.0MN/A-
Valuation Analysis

Current Valuation Metrics

City Therapeutics is currently valued at $285.5M as of October 8, 2024. The company has raised a total of $139.5M in funding across 1 funding round.

Capital Efficiency

With a capital efficiency ratio of 2.05x, City Therapeutics has achieved a valuation that is 2.05 times the total capital raised.

Track City Therapeutics Valuation Updates

Get notified when City Therapeutics raises new funding or valuation changes

View 5 companies free

Create a free account to unlock City Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is City Therapeutics Worth in 2026?

City Therapeutics is a leading private company in the Drug Discovery sector. Track City Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How City Therapeutics Valuation is Determined

Private company valuations like City Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.